GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Morepen Laboratories Ltd (BOM:500288) » Definitions » 3-Year Book Growth Rate

Morepen Laboratories (BOM:500288) 3-Year Book Growth Rate : 20.60% (As of Sep. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Morepen Laboratories 3-Year Book Growth Rate?

Morepen Laboratories's Book Value per Share for the quarter that ended in Sep. 2024 was ₹20.27.

During the past 12 months, Morepen Laboratories's average Book Value per Share Growth Rate was 31.30% per year. During the past 3 years, the average Book Value per Share Growth Rate was 20.60% per year. During the past 5 years, the average Book Value per Share Growth Rate was 26.40% per year. During the past 10 years, the average Book Value per Share Growth Rate was 12.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Morepen Laboratories was 32.60% per year. The lowest was -30.80% per year. And the median was -4.80% per year.


Competitive Comparison of Morepen Laboratories's 3-Year Book Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Morepen Laboratories's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Morepen Laboratories's 3-Year Book Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Morepen Laboratories's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Morepen Laboratories's 3-Year Book Growth Rate falls into.



Morepen Laboratories 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.


Morepen Laboratories  (BOM:500288) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.


Morepen Laboratories 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Morepen Laboratories's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Morepen Laboratories Business Description

Traded in Other Exchanges
Address
Udyog Vihar-III, Sector-20, 2nd Floor, Tower C, DLF Cyber Park, Gurugram, HR, IND, 122016
Morepen Laboratories Ltd is in the business of manufacturing, producing, developing, and marketing various Active Pharmaceutical Ingredients (APIs), branded and generic formulations, and also Home Health products. Some of the products offered by the company include various drug formulations, APIs, digital thermometers, heat belts, pulse oximeters, nutritional tablets, pain sprays, and others. The company operates in a single segment namely, Pharmaceuticals. Geographically, the company derives maximum revenue from India and the rest from the United States of America, and the Rest of the world.

Morepen Laboratories Headlines

No Headlines